Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma.
Saved in:
| Title: | Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. |
|---|---|
| Authors: | Chamseddine S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yavuz BG; Department of Internal Medicine, University of Missouri, Columbia, MO, USA., Mohamed YI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lee SS; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yao JC; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu ZI; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., LaPelusa M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xiao L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Morris JS; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Hatia RI; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hassan M; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Duda DG; Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Diab M; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA., Mohamed A; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA., Nassar A; Department of Surgery, Emory University, Atlanta, GA, USA., Amin HM; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA., Kaseb AO; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. |
| Source: | Journal of immunotherapy and precision oncology [J Immunother Precis Oncol] 2024 Nov 01; Vol. 7 (4), pp. 255-262. Date of Electronic Publication: 2024 Nov 01 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Innovative Healthcare Institute Country of Publication: United States NLM ID: 101768397 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-017X (Electronic) Linking ISSN: 2590017X NLM ISO Abbreviation: J Immunother Precis Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39524465 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Chamseddine+S%22">Chamseddine S</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yavuz+BG%22">Yavuz BG</searchLink>; Department of Internal Medicine, University of Missouri, Columbia, MO, USA.<br /><searchLink fieldCode="AU" term="%22Mohamed+YI%22">Mohamed YI</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Lee+SS%22">Lee SS</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Yao+JC%22">Yao JC</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hu+ZI%22">Hu ZI</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22LaPelusa+M%22">LaPelusa M</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Xiao+L%22">Xiao L</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Sun+R%22">Sun R</searchLink>; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Morris+JS%22">Morris JS</searchLink>; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hatia+RI%22">Hatia RI</searchLink>; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Hassan+M%22">Hassan M</searchLink>; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Duda+DG%22">Duda DG</searchLink>; Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Diab+M%22">Diab M</searchLink>; Department of Hematology and Oncology, Winship Cancer Institute, Emory University, Atlanta, GA.<br /><searchLink fieldCode="AU" term="%22Mohamed+A%22">Mohamed A</searchLink>; Division of Hematology and Oncology, Department of Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.<br /><searchLink fieldCode="AU" term="%22Nassar+A%22">Nassar A</searchLink>; Department of Surgery, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Amin+HM%22">Amin HM</searchLink>; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Kaseb+AO%22">Kaseb AO</searchLink>; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101768397%22">Journal of immunotherapy and precision oncology</searchLink> [J Immunother Precis Oncol] 2024 Nov 01; Vol. 7 (4), pp. 255-262. <i>Date of Electronic Publication: </i>2024 Nov 01 (<i>Print Publication: </i>2024). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Innovative+Healthcare+Institute%22">Innovative Healthcare Institute </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101768397 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2590-017X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222590017X%22">2590017X </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Precis Oncol <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39524465 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.36401/JIPO-24-6 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 255 Titles: – TitleFull: Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Chamseddine S – PersonEntity: Name: NameFull: Yavuz BG – PersonEntity: Name: NameFull: Mohamed YI – PersonEntity: Name: NameFull: Lee SS – PersonEntity: Name: NameFull: Yao JC – PersonEntity: Name: NameFull: Hu ZI – PersonEntity: Name: NameFull: LaPelusa M – PersonEntity: Name: NameFull: Xiao L – PersonEntity: Name: NameFull: Sun R – PersonEntity: Name: NameFull: Morris JS – PersonEntity: Name: NameFull: Hatia RI – PersonEntity: Name: NameFull: Hassan M – PersonEntity: Name: NameFull: Duda DG – PersonEntity: Name: NameFull: Diab M – PersonEntity: Name: NameFull: Mohamed A – PersonEntity: Name: NameFull: Nassar A – PersonEntity: Name: NameFull: Amin HM – PersonEntity: Name: NameFull: Kaseb AO IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 11 Text: 2024 Nov 01 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2590-017X Numbering: – Type: volume Value: 7 – Type: issue Value: 4 Titles: – TitleFull: Journal of immunotherapy and precision oncology Type: main |
| ResultId | 1 |
